Treatment options for high-risk and extremely high-risk localized prostate cancer
10.3969/j.issn.1009-8291.2025.03.002
- VernacularTitle:高危和极高危局限性前列腺癌的治疗选择
- Author:
Kuiqing LI
1
;
Yousheng YAO
1
Author Information
1. Department of Urology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou 510000, China
- Publication Type:Journal Article
- Keywords:
localized prostate cancer;
high-risk;
extremely high-risk;
radiotherapy;
radical prostatectomy;
novel endocrinotherapy;
immunotherapy;
targeted therapy;
lymph node dissection;
systemic treatment
- From:
Journal of Modern Urology
2025;30(3):188-192
- CountryChina
- Language:Chinese
-
Abstract:
In the treatment of high-risk and extremely high-risk localized prostate cancer，urologists，radiation therapists and oncologists have different opinions. With the development of new systemic therapy drugs and the application of genetic testing，treatment methods are constantly evolving. This article reviews the latest research progress，including radical prostatectomy，lymph node dissection，radiotherapy，and systemic treatment regimens (docetaxel-based therapy，novel endocrinotherapy，immunotherapy，targeted therapy)，to systematically evaluate the long-term survival and tumor control efficacy of different treatment methods，so as to provide clinical reference.
